When it comes to CLL/SLL treatment, what’s the difference between BTK inhibitors and BCL-2 inhibitors? Understanding how these treatment approaches work and how they fit into the treatment…
BTK degrader BGB-16673 reduced tumor burden in 85% of patients from a high-risk, hard-to-treat group with relapsed / refractory CLL. Dr. Stephan Stilgenbauer from Ulm University and colleagues…
About 40 thousand women die each year of breast cancer in the United States. Mammography screening is one way to detect breast cancer early. However, mammograms have benefits…
Human Papillomavirus or HPV is one of the most common sexually transmitted infections. The infection is important to prevent because it can cause cervical cancer and genital warts.…
NEW YORK (Reuters Health) – The extent of resection and residual volume are independently tied to survival and recurrence after surgery for newly diagnosed glioblastoma, according to a…
By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
NEW YORK (Reuters Health) – Although trastuzumab is directed against the HER2 protein, patients with HER2-negative breast cancer may also benefit from adjuvant trastuzumab therapy, researchers report. They…
NEW YORK (Reuters Health) – How much an individual patient with esophageal cancer is likely to benefit, if at all, from chemoradiotherapy (CRT) before undergoing esophagectomy can be…
NEW YORK (Reuters Health) – A diagnosis of bladder cancer after an initial presentation with hematuria is often delayed in both men and women – but the delay…
NEW YORK (Reuters Health) – A preoperative MRI showing whether or not a rectal tumor encroaches on the circumferential resection margin (CRM) is a better predictor of recurrence…
Martin Lee, author of Smoke Signals, and director of Project CBD, explains why doctors may find themselves in a difficult position when patients come to them with questions about medical…
